SEC Form 4 · accession 0001615594-15-000052
UROLOGIX INC · ULGX
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Scott M. Madson
Officer — Chief Financial Officer
Period of report
Apr 1, 2015
Accepted (ET)
Apr 2, 2015 · 1:23 pm EDT
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0000882873
Table I — non-derivative securities
No Table I lines on this filing.
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Stock Option (Right-to-Buy)F1 | $0.08 | Apr 1, 2015 | A | 150,000 | A | Apr 1, 2016 | Apr 1, 2025 | Common Stock | 150,000 | 150,000 | D |
Explanation of responses
- F1Option vests as to 25% of the shares on the first anniversary of the grant date; and thereafter, as to 1/36th of the remaining shares underlying the option on the monthly anniversary of the grant date for each of the next 36 months.